Nalaganje...
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL
This phase 2 study was conducted to prospectively evaluate how clinical and biological factors correlate with outcome in patients with treatment-naive (TN) and relapsed (R) chronic lymphocytic leukemia (CLL) treated with lenalidomide and rituximab. Oral lenalidomide 10 mg was administered daily star...
Shranjeno v:
| izdano v: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517659/ https://ncbi.nlm.nih.gov/pubmed/31076409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019031336 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|